HIV usually infects blood cells through a protein on their surface, a “docking station” called CCR5. A California company, Sangamo BioSciences Inc. (NASDAQ:SGMO), makes a treatment that can knock out a gene that makes CCR5. Sangamo Biosciences, Inc. (NASDAQ:SGMO) stock performance was 17.08% in last session and finished the day at $22.96. Traded volume was 11.36 million shares in the last session and the average … Continue reading Hot Biotech Gainers: Sangamo Biosciences (NASDAQ:SGMO), CEL-SCI Corporation (NYSEMKT:CVM), Agios Pharmaceuticals (NASDAQ:AGIO), Lpath (NASDAQ:LPTN)